Latest News for 06/2018
April 2018
-
04 Apr 2018In a paper just published in Molecular Cell, Dominka Kwasna from Yogesh Kulathu’s group at the MRC PPU, in collaboration with Ian Gibbs-Seymour at the University of Oxford, reports the discovery of a completely new class of enzymes that is important for protecting the cell’s DNA from damage.
September 2017
-
26 Sep 2017This year, our traditional poster session for PhD students entering into their third year formed part of a Dundee-Tokyo Postgraduate Student Research Symposium, including a group of PhD students and academics from University of Tokyo.
June 2017
-
12 Jun 2017Yogesh Kulathu from the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) has been awarded a 2017 Lister Research Prize. This prestigious and highly sought-after prize is given annually by the Lister Institute of Preventive Medicine to up to five young researchers in the UK. These awards are intended to help support and nurture future leaders of biomedical research.
June 2016
-
10 Jun 2016In ground-breaking new work published in Molecular Cell, Yogesh Kulathu and colleagues report the discovery of a completely new family of Deubiquitinating enzymes (DUBs). Ubiquitin signals impact a wide range of eukaryotic biology. It is therefore very important that these signals are tightly regulated. This layer of regulation is provided by dedicated proteases called deubiquitinating enzymes (DUBs), of which there are ~100 encoded in the human genome that can be classified into five families.
December 2015
-
08 Dec 2015Yogesh Kulathu awarded €1.5 million ERC Starting Grant Dr. Yogesh Kulathu has been awarded an ERC Starting Grant of €1.5 million which will allow him to initiate an ambitious new project to understand how T-cell biology is regulated by the ubiquitin system.
November 2013
-
CLS researchers strengthen links with scientists at the National Centre for Biological Sciences (...20 Nov 2013Collaboration between life sciences research in Dundee and India was consolidated last week (11-16 November 2013) by a team of CLS Principal Investigators who visited the National Centre for Biological Sciences (NCBS) and the Institute for Stem Cell Biology and Regenerative Medicine (inStem) in Bangalore to explore mutual scientific interests and future projects.
